PTGX PROTAGONIST THERAPEUTICS INC More: the full row for PROTAGONIST THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,498,545 shares; 2025Q1: 5,719,415 shares; 2025Q2: 5,756,277 shares; 2025Q3: 5,756,277 shares; 2025Q4: 5,059,053 shares; 2026Q1: 5,059,053 shares; 2026Q2: 5,061,175 shares; 2026Q3: 5,061,175 shares 5,061,175 $713M 7.19% 0 Timeline ARGX ARGENX SE More: the full row for ARGENX SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 673,497 shares; 2025Q1: 673,497 shares; 2025Q2: 673,497 shares; 2025Q3: 673,497 shares; 2025Q4: 673,497 shares; 2026Q1: 709,446 shares; 2026Q2: 709,446 shares; 2026Q3: 711,584 shares 711,584 $682M 6.88% +2,138 Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,701,216 shares; 2025Q1: 1,701,216 shares; 2025Q2: 1,701,216 shares; 2025Q3: 1,701,216 shares; 2025Q4: 2,012,127 shares; 2026Q1: 6,984,808 shares; 2026Q2: 8,514,590 shares; 2026Q3: 8,514,590 shares 8,514,590 $604M 6.08% 0 Timeline IRTC IRHYTHM HOLDINGS INC More: the full row for IRHYTHM HOLDINGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,181,990 shares; 2026Q1: 1,668,500 shares; 2026Q2: 2,182,631 shares; 2026Q3: 3,118,913 shares 3,118,913 $354M 3.57% +936,282 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,014,558 shares; 2025Q1: 3,014,558 shares; 2025Q2: 3,084,558 shares; 2025Q3: 3,084,558 shares; 2025Q4: 4,842,879 shares; 2026Q1: 4,842,880 shares; 2026Q2: 4,842,880 shares; 2026Q3: 3,096,545 shares 3,096,545 $353M 3.56% -1,746,335 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,491,228 shares; 2026Q1: 13,300,620 shares; 2026Q2: 13,900,620 shares; 2026Q3: 14,048,477 shares 14,048,477 $351M 3.53% +147,857 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 146,651 shares; 2026Q1: 16,157,175 shares; 2026Q2: 17,946,754 shares; 2026Q3: 22,446,754 shares 22,446,754 $329M 3.32% +4,500,000 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,621,996 shares; 2025Q1: 3,621,996 shares; 2025Q2: 3,621,996 shares; 2025Q3: 3,621,996 shares; 2025Q4: 4,171,996 shares; 2026Q1: 4,171,996 shares; 2026Q2: 4,251,996 shares; 2026Q3: 3,691,791 shares 3,691,791 $329M 3.31% -560,205 Timeline RDNT RADNET INC More: the full row for RADNET INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,978,582 shares; 2025Q1: 2,317,582 shares; 2025Q2: 2,690,344 shares; 2025Q3: 2,815,544 shares; 2025Q4: 3,938,500 shares; 2026Q1: 4,285,000 shares; 2026Q2: 4,846,958 shares; 2026Q3: 4,630,697 shares 4,630,697 $319M 3.22% -216,261 Timeline TARS TARSUS PHARMACEUTICALS INC More: the full row for TARSUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,236,549 shares; 2025Q1: 3,316,032 shares; 2025Q2: 3,111,680 shares; 2025Q3: 3,177,436 shares; 2025Q4: 3,335,320 shares; 2026Q1: 3,346,025 shares; 2026Q2: 3,357,059 shares; 2026Q3: 3,484,066 shares 3,484,066 $274M 2.76% +127,007 Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,509,119 shares; 2025Q1: 3,136,680 shares; 2025Q2: 5,536,876 shares; 2025Q3: 2,291,372 shares; 2025Q4: 6,959,032 shares; 2026Q1: 6,574,032 shares; 2026Q2: 6,574,032 shares; 2026Q3: 10,350,973 shares 10,350,973 $273M 2.75% +3,776,941 Timeline RGEN REPLIGEN CORP More: the full row for REPLIGEN CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,064,000 shares; 2026Q1: 1,206,000 shares; 2026Q2: 1,240,637 shares; 2026Q3: 1,385,398 shares 1,385,398 $266M 2.68% +144,761 Timeline GH GUARDANT HEALTH INC More: the full row for GUARDANT HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 856,501 shares; 2025Q3: 1,481,033 shares; 2025Q4: 1,481,033 shares; 2026Q1: 1,481,033 shares; 2026Q2: 1,481,033 shares; 2026Q3: 1,481,033 shares 1,481,033 $264M 2.66% 0 Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 550,160 shares; 2026Q1: 3,039,621 shares; 2026Q2: 3,304,903 shares; 2026Q3: 3,304,903 shares 3,304,903 $263M 2.65% 0 Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,945,649 shares; 2025Q1: 1,945,649 shares; 2025Q2: 1,945,649 shares; 2025Q3: 1,945,649 shares; 2025Q4: 2,058,148 shares; 2026Q1: 2,058,148 shares; 2026Q2: 3,139,030 shares; 2026Q3: 3,139,030 shares 3,139,030 $261M 2.64% 0 Timeline NTRA NATERA INC More: the full row for NATERA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,593,323 shares; 2025Q1: 2,593,546 shares; 2025Q2: 2,593,645 shares; 2025Q3: 2,000,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,250,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 600,000 shares 600,000 $248M 2.5% -400,000 Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,721,158 shares; 2025Q1: 2,721,158 shares; 2025Q2: 2,721,158 shares; 2025Q3: 2,721,158 shares; 2025Q4: 2,721,158 shares; 2026Q1: 2,721,158 shares; 2026Q2: 2,862,003 shares; 2026Q3: 2,862,003 shares 2,862,003 $189M 1.9% 0 Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,834,794 shares; 2025Q1: 3,834,794 shares; 2025Q2: 4,543,895 shares; 2025Q3: 4,543,895 shares; 2025Q4: 4,543,895 shares; 2026Q1: 4,543,895 shares; 2026Q2: 4,543,895 shares; 2026Q3: 4,543,895 shares 4,543,895 $185M 1.86% 0 Timeline ESTA ESTABLISHMENT LABS HLDGS INC More: the full row for ESTABLISHMENT LABS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,569,687 shares; 2025Q1: 2,583,887 shares; 2025Q2: 2,584,131 shares; 2025Q3: 2,588,831 shares; 2025Q4: 2,588,831 shares; 2026Q1: 2,655,695 shares; 2026Q2: 2,655,695 shares; 2026Q3: 2,665,695 shares 2,665,695 $171M 1.72% +10,000 Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,402,883 shares; 2025Q1: 2,402,883 shares; 2025Q2: 2,402,883 shares; 2025Q3: 6,221,054 shares; 2025Q4: 6,777,461 shares; 2026Q1: 6,777,461 shares; 2026Q2: 6,777,461 shares; 2026Q3: 6,827,461 shares 6,827,461 $170M 1.72% +50,000 Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,993,687 shares; 2025Q1: 1,993,687 shares; 2025Q2: 1,993,687 shares; 2025Q3: 1,993,687 shares; 2025Q4: 1,993,687 shares; 2026Q1: 1,993,687 shares; 2026Q2: 1,993,687 shares; 2026Q3: 312,817 shares 312,817 $158M 1.59% -1,680,870 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,869,798 shares; 2025Q1: 4,869,798 shares; 2025Q2: 4,869,798 shares; 2025Q3: 4,869,798 shares; 2025Q4: 4,869,798 shares; 2026Q1: 4,869,798 shares; 2026Q2: 4,869,798 shares; 2026Q3: 4,869,798 shares 4,869,798 $148M 1.49% 0 Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,123,525 shares; 2025Q1: 5,123,525 shares; 2025Q2: 5,123,525 shares; 2025Q3: 5,123,525 shares; 2025Q4: 5,546,856 shares; 2026Q1: 5,623,525 shares; 2026Q2: 5,623,525 shares; 2026Q3: 5,623,525 shares 5,623,525 $146M 1.47% 0 Timeline ACAD ACADIA PHARMACEUTICALS INC More: the full row for ACADIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,705,501 shares; 2025Q1: 8,540,117 shares; 2025Q2: 8,995,547 shares; 2025Q3: 7,144,524 shares; 2025Q4: 7,144,524 shares; 2026Q1: 7,144,524 shares; 2026Q2: 7,144,524 shares; 2026Q3: 7,144,524 shares 7,144,524 $144M 1.45% 0 Timeline KOD KODIAK SCIENCES INC More: the full row for KODIAK SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,487,933 shares; 2026Q1: 1,487,934 shares; 2026Q2: 1,487,934 shares; 2026Q3: 1,487,934 shares 1,487,934 $141M 1.42% 0 Timeline GHRS GH RESEARCH PLC More: the full row for GH RESEARCH PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,327,129 shares; 2025Q1: 5,499,769 shares; 2025Q2: 5,540,457 shares; 2025Q3: 5,569,564 shares; 2025Q4: 5,933,815 shares; 2026Q1: 5,933,815 shares; 2026Q2: 5,933,815 shares; 2026Q3: 5,933,815 shares 5,933,815 $139M 1.4% 0 Timeline CMPS COMPASS PATHWAYS PLC More: the full row for COMPASS PATHWAYS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,098,987 shares; 2025Q1: 5,538,168 shares; 2025Q2: 8,221,929 shares; 2025Q3: 8,707,390 shares; 2025Q4: 8,757,390 shares; 2026Q1: 10,632,390 shares; 2026Q2: 10,700,974 shares; 2026Q3: 10,948,591 shares 10,948,591 $136M 1.37% +247,617 Timeline NBIX NEUROCRINE BIOSCIENCES INC More: the full row for NEUROCRINE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,062,072 shares; 2025Q3: 1,062,072 shares; 2025Q4: 1,062,072 shares; 2026Q1: 1,062,072 shares; 2026Q2: 1,267,925 shares; 2026Q3: 942,684 shares 942,684 $134M 1.35% -325,241 Timeline RARE ULTRAGENYX PHARMACEUTICAL IN More: the full row for ULTRAGENYX PHARMACEUTICAL IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,968,002 shares; 2025Q1: 1,707,402 shares; 2025Q2: 1,707,402 shares; 2025Q3: 3,258,266 shares; 2025Q4: 3,000,139 shares; 2026Q1: 3,648,795 shares; 2026Q2: 7,796,895 shares; 2026Q3: 8,529,394 shares 8,529,394 $128M 1.29% +732,499 Timeline KLRA KAILERA THERAPEUTICS INC More: the full row for KAILERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,776,820 shares; 2026Q3: 10,776,820 shares 10,776,820 $123M 1.24% 0 Timeline BLTE BELITE BIO INC More: the full row for BELITE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 312,500 shares; 2025Q4: 715,332 shares; 2026Q1: 715,332 shares; 2026Q2: 715,332 shares; 2026Q3: 715,332 shares 715,332 $121M 1.22% 0 Timeline IMTX IMMATICS N.V More: the full row for IMMATICS N.V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,540,540 shares; 2025Q1: 6,909,510 shares; 2025Q2: 6,970,152 shares; 2025Q3: 8,815,617 shares; 2025Q4: 11,433,354 shares; 2026Q1: 12,869,340 shares; 2026Q2: 12,946,176 shares; 2026Q3: 13,521,551 shares 13,521,551 $119M 1.2% +575,375 Timeline REPL REPLIMUNE GROUP INC More: the full row for REPLIMUNE GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,065,010 shares; 2025Q1: 2,065,010 shares; 2025Q2: 2,065,010 shares; 2025Q3: 6,395,732 shares; 2025Q4: 7,140,352 shares; 2026Q1: 7,356,916 shares; 2026Q2: 7,411,581 shares; 2026Q3: 8,491,525 shares 8,491,525 $112M 1.13% +1,079,944 Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 530,614 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,177,850 shares; 2026Q1: 3,177,849 shares; 2026Q2: 3,177,849 shares; 2026Q3: 3,177,849 shares 3,177,849 $107M 1.08% 0 Timeline PTCT PTC THERAPEUTICS INC More: the full row for PTC THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,393,127 shares; 2025Q1: 7,483,127 shares; 2025Q2: 7,746,415 shares; 2025Q3: 7,746,415 shares; 2025Q4: 7,746,415 shares; 2026Q1: 7,746,415 shares; 2026Q2: 7,746,415 shares; 2026Q3: 1,615,819 shares 1,615,819 $105M 1.06% -6,130,596 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,910,126 shares 4,910,126 $101M 1.02% new Timeline CSTL CASTLE BIOSCIENCES INC More: the full row for CASTLE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,115,237 shares; 2026Q1: 2,758,335 shares; 2026Q2: 2,778,335 shares; 2026Q3: 2,778,335 shares 2,778,335 $98.7M 0.99% 0 Timeline QURE UNIQURE NV More: the full row for UNIQURE NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 903,625 shares; 2025Q1: 4,265,428 shares; 2025Q2: 5,158,231 shares; 2025Q3: 4,424,968 shares; 2025Q4: 3,711,462 shares; 2026Q1: 2,586,356 shares; 2026Q2: 3,941,572 shares; 2026Q3: 3,941,572 shares 3,941,572 $95.2M 0.96% 0 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,467,486 shares; 2025Q4: 7,592,241 shares; 2026Q1: 5,458,675 shares; 2026Q2: 2,309,021 shares; 2026Q3: 2,309,021 shares 2,309,021 $73.9M 0.75% 0 Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 125,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares; 2026Q1: not reported; 2026Q2: 1,607,507 shares; 2026Q3: 2,282,138 shares 2,282,138 $71.4M 0.72% +674,631 Timeline AXGN AXOGEN INC More: the full row for AXOGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,011,576 shares; 2026Q3: 1,659,376 shares 1,659,376 $69.6M 0.7% +647,800 Timeline TSHA TAYSHA GENE THERAPIES INC More: the full row for TAYSHA GENE THERAPIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,672,630 shares; 2025Q1: 18,787,866 shares; 2025Q2: 25,021,584 shares; 2025Q3: 24,354,291 shares; 2025Q4: 16,398,297 shares; 2026Q1: 13,680,248 shares; 2026Q2: 13,560,258 shares; 2026Q3: 13,560,258 shares 13,560,258 $66M 0.67% 0 Timeline OBIO ORCHESTRA BIOMED HLDGS INC More: the full row for ORCHESTRA BIOMED HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,206,162 shares; 2025Q1: 8,206,162 shares; 2025Q2: 8,306,062 shares; 2025Q3: 8,306,063 shares; 2025Q4: 8,306,063 shares; 2026Q1: 8,306,063 shares; 2026Q2: 9,556,063 shares; 2026Q3: 9,556,063 shares 9,556,063 $59.4M 0.6% 0 2026-11-09, 13D/A : 13,142,394 shares, 16.2% of the class, 13D/A filed 2026-11-12 Timeline VSTM VERASTEM INC More: the full row for VERASTEM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 4,245,476 shares; 2025Q2: 4,251,616 shares; 2025Q3: 5,426,306 shares; 2025Q4: 6,576,306 shares; 2026Q1: 6,576,306 shares; 2026Q2: 6,635,793 shares; 2026Q3: 6,718,081 shares 6,718,081 $54.1M 0.55% +82,288 Timeline DHR DANAHER CORP DEL More: the full row for DANAHER CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 230,000 shares; 2026Q3: 230,000 shares 230,000 $51M 0.51% 0 Timeline HNGE HINGE HEALTH INC More: the full row for HINGE HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 353,500 shares; 2026Q1: 1,930,000 shares; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000 $48.6M 0.49% 0 Timeline RCKT ROCKET PHARMACEUTICALS INC More: the full row for ROCKET PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 17,687,772 shares; 2025Q1: 17,687,772 shares; 2025Q2: 17,687,772 shares; 2025Q3: 17,687,772 shares; 2025Q4: 17,687,772 shares; 2026Q1: 17,687,772 shares; 2026Q2: 17,687,772 shares; 2026Q3: 17,687,772 shares 17,687,772 $46.5M 0.47% 0 Timeline SLDB SOLID BIOSCIENCES INC More: the full row for SOLID BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,892,926 shares; 2026Q3: 5,905,426 shares 5,905,426 $42.7M 0.43% +2,012,500 Timeline NGNE NEUROGENE INC More: the full row for NEUROGENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,350,256 shares; 2025Q1: 1,348,656 shares; 2025Q2: 1,362,456 shares; 2025Q3: 1,362,456 shares; 2025Q4: 1,362,456 shares; 2026Q1: 1,362,456 shares; 2026Q2: 1,362,456 shares; 2026Q3: 1,512,456 shares 1,512,456 $42.1M 0.42% +150,000 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,705,960 shares; 2025Q1: 1,705,960 shares; 2025Q2: 1,705,960 shares; 2025Q3: 1,705,960 shares; 2025Q4: 1,705,960 shares; 2026Q1: 1,705,960 shares; 2026Q2: 2,364,347 shares; 2026Q3: 2,364,347 shares 2,364,347 $36.3M 0.37% 0 Timeline AQST AQUESTIVE THERAPEUTICS INC More: the full row for AQUESTIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,250,000 shares; 2025Q4: 6,250,000 shares; 2026Q1: 7,426,471 shares; 2026Q2: 7,426,471 shares; 2026Q3: 7,426,471 shares 7,426,471 $34.4M 0.35% 0 Timeline CADL CANDEL THERAPEUTICS INC More: the full row for CANDEL THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,422,018 shares; 2026Q2: 6,422,018 shares; 2026Q3: 3,211,008 shares 3,211,008 $33.5M 0.34% -3,211,010 Timeline AKTS AKTIS ONCOLOGY INC More: the full row for AKTIS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,592,043 shares; 2026Q2: 1,592,043 shares; 2026Q3: 1,592,043 shares 1,592,043 $31M 0.31% 0 Timeline SVRA SAVARA INC More: the full row for SAVARA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,952,380 shares; 2026Q1: 5,952,380 shares; 2026Q2: 5,952,380 shares; 2026Q3: 5,952,380 shares 5,952,380 $30.7M 0.31% 0 Timeline KRSA KORSANA BIOSCIENCES INC More: the full row for KORSANA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 877,020 shares 877,020 $28.1M 0.28% new Timeline KYMR KYMERA THERAPEUTICS INC More: the full row for KYMERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 240,000 shares; 2026Q1: 240,000 shares; 2026Q2: 240,000 shares; 2026Q3: 240,000 shares 240,000 $26.8M 0.27% 0 Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 666,667 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 248,063 shares; 2026Q2: 248,063 shares; 2026Q3: 248,063 shares 248,063 $21.8M 0.22% 0 Timeline BBNX BETA BIONICS INC More: the full row for BETA BIONICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,299,870 shares; 2025Q2: 3,299,191 shares; 2025Q3: 3,299,191 shares; 2025Q4: 2,500,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 998,855 shares 998,855 $19M 0.19% -501,145 Timeline LRMR LARIMAR THERAPEUTICS INC More: the full row for LARIMAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,125,000 shares; 2025Q4: 3,125,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 2,565,999 shares; 2026Q3: 5,820,891 shares 5,820,891 $18.6M 0.19% +3,254,892 Timeline PYXS PYXIS ONCOLOGY INC More: the full row for PYXIS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 6,506,229 shares 6,506,229 $15.2M 0.15% new Timeline IPSC CENTURY THERAPEUTICS INC More: the full row for CENTURY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,695,652 shares; 2026Q2: 8,695,652 shares; 2026Q3: 8,695,652 shares 8,695,652 $14.9M 0.15% 0 Timeline BEAM BEAM THERAPEUTICS INC More: the full row for BEAM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 438,659 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 570,394 shares; 2026Q1: 570,394 shares; 2026Q2: 570,394 shares; 2026Q3: 570,394 shares 570,394 $13.9M 0.14% 0 Timeline SRZN SURROZEN INC More: the full row for SURROZEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 393,560 shares 393,560 $12.7M 0.13% new Timeline HTFL HEARTFLOW INC More: the full row for HEARTFLOW INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 495,000 shares; 2025Q4: 495,000 shares; 2026Q1: 495,000 shares; 2026Q2: 295,000 shares; 2026Q3: 250,000 shares 250,000 $12.4M 0.13% -45,000 Timeline FRNM FREENOME INC More: the full row for FREENOME INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 742,500 shares 742,500 $11.7M 0.12% new Timeline LTGO LATIGO BIOTHERAPEUTICS INC More: the full row for LATIGO BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 700,000 shares 700,000 $11.7M 0.12% new Timeline SLN SILENCE THERAPEUTICS PLC More: the full row for SILENCE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 700,000 shares 700,000 $7.65M 0.08% new Timeline OCGN OCUGEN INC More: the full row for OCUGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,666,666 shares; 2026Q2: 6,666,666 shares; 2026Q3: 6,666,666 shares 6,666,666 $6.87M 0.07% 0 Timeline MIST MILESTONE PHARMACEUTICALS IN More: the full row for MILESTONE PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,506,102 shares; 2025Q1: 2,506,102 shares; 2025Q2: 2,506,102 shares; 2025Q3: 2,506,102 shares; 2025Q4: 2,506,102 shares; 2026Q1: 6,331,001 shares; 2026Q2: 7,833,336 shares; 2026Q3: 7,833,336 shares 7,833,336 $6.78M 0.07% 0 Timeline ADRX ADARX PHARMACEUTICALS INC More: the full row for ADARX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $5.98M 0.06% new Timeline CBIO CRESCENT BIOPHARMA INC. More: the full row for CRESCENT BIOPHARMA INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 372,856 shares; 2026Q1: 372,856 shares; 2026Q2: 372,856 shares; 2026Q3: 372,856 shares 372,856 $5.44M 0.05% 0 Timeline ALLO ALLOGENE THERAPEUTICS INC More: the full row for ALLOGENE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,250,000 shares; 2026Q3: 3,250,000 shares 3,250,000 $5.2M 0.05% 0 Timeline LMRI LUMEXA IMAGING HOLDINGS INC More: the full row for LUMEXA IMAGING HOLDINGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 650,000 shares; 2026Q1: 650,000 shares; 2026Q2: 650,000 shares; 2026Q3: 500,000 shares 500,000 $5.12M 0.05% -150,000 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,218,641 shares; 2025Q1: 1,690,567 shares; 2025Q2: 1,690,567 shares; 2025Q3: 2,890,567 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $4.83M 0.05% new Timeline RGNX REGENXBIO INC More: the full row for REGENXBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 350,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 555,555 shares 555,555 $4.18M 0.04% new Timeline KLRS KALARIS THERAPEUTICS INC More: the full row for KALARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,300,000 shares; 2026Q1: 1,300,000 shares; 2026Q2: 1,300,000 shares; 2026Q3: 1,300,000 shares 1,300,000 $3.76M 0.04% 0 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 350,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 26,400 shares; 2026Q3: 26,400 shares 26,400 $2.61M 0.03% 0 Timeline MDLN MEDLINE INC More: the full row for MEDLINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,000 shares; 2026Q1: 70,000 shares; 2026Q2: 70,000 shares; 2026Q3: 70,000 shares 70,000 $2.43M 0.02% 0 Timeline CAPR CAPRICOR THERAPEUTICS INC More: the full row for CAPRICOR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000 $2.37M 0.02% 0 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares; 2026Q2: 30,000 shares; 2026Q3: 30,000 shares 30,000 $1.96M 0.02% 0 Timeline EVMN EVOMMUNE INC More: the full row for EVOMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,283,671 shares; 2026Q1: 1,502,235 shares; 2026Q2: 1,502,235 shares; 2026Q3: 208,071 shares 208,071 $1.72M 0.02% -1,294,164 Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 67,706 shares 67,706 $930K 0.01% new Timeline LXEO LEXEO THERAPEUTICS INC More: the full row for LEXEO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 239,149 shares 239,149 $808K 0.01% new Timeline